Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
Kidney International
|
June 25, 2018
Youthful systemic milieu alleviates renal ischemia-reperfusion injury in elderly mice
Dong Liu, Lide Lun, Qi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2021
Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Zhi Peng, Jia Wei, Feng Wang, et al.
Aging
|
April 13, 2019
Exogenous biological renal support ameliorates renal pathology after ischemia reperfusion injury in elderly mice
Dong Liu, Zhiwei Yin, Qi Huang, et al.
Pharmacological Research
|
November 11, 2022
The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis
Jiujie Yang, Zhi Li, Linna Wang, et al.
Pharmaceutical Research
|
July 31, 2023
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
Jessica Chu, Erika Panfen, Linna Wang, et al.
The Lancet. Oncology
|
March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Shukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Liver Cancer
|
November 1, 2021
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Zhenggang Ren, Shukui Qin, Zhiqiang Meng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
November 4, 2022
An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology
Yan Zhang, Xinru Gu, Yanyan Zhou, et al.
Data in Brief
|
January 21, 2026
Characterization of the complete mitochondrial genome data of the allotriploid grouper <i>Epinephelus fuscoguttatus</i> ♀× <i>Epinephelus tukula</i> ♂
Zhentong Li, Linlin Li, Yuan Deng, et al.
Clinical Immunology (Orlando, Fla.)
|
December 8, 2023
Huanglian Jiedu Wan intervened with "Shi-Re Shanghuo" syndrome through regulating immune balance mediated by biomarker succinate
Keke Luo, Haiyu Zhao, Mengxiao Wang, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
Kidney International
|
June 25, 2018
Youthful systemic milieu alleviates renal ischemia-reperfusion injury in elderly mice
Dong Liu, Lide Lun, Qi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2021
Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Zhi Peng, Jia Wei, Feng Wang, et al.
Aging
|
April 13, 2019
Exogenous biological renal support ameliorates renal pathology after ischemia reperfusion injury in elderly mice
Dong Liu, Zhiwei Yin, Qi Huang, et al.
Pharmacological Research
|
November 11, 2022
The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis
Jiujie Yang, Zhi Li, Linna Wang, et al.
Pharmaceutical Research
|
July 31, 2023
Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
Jessica Chu, Erika Panfen, Linna Wang, et al.
The Lancet. Oncology
|
March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Shukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Liver Cancer
|
November 1, 2021
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Zhenggang Ren, Shukui Qin, Zhiqiang Meng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
November 4, 2022
An integrative analysis of Qingfei Paidu Decoction for its anti-HCoV-229E mechanism in cold and damp environment based on the pharmacokinetics, metabolomics and molecular docking technology
Yan Zhang, Xinru Gu, Yanyan Zhou, et al.
Data in Brief
|
January 21, 2026
Characterization of the complete mitochondrial genome data of the allotriploid grouper <i>Epinephelus fuscoguttatus</i> ♀× <i>Epinephelus tukula</i> ♂
Zhentong Li, Linlin Li, Yuan Deng, et al.
Clinical Immunology (Orlando, Fla.)
|
December 8, 2023
Huanglian Jiedu Wan intervened with "Shi-Re Shanghuo" syndrome through regulating immune balance mediated by biomarker succinate
Keke Luo, Haiyu Zhao, Mengxiao Wang, et al.
Page
of 16